4.1 Review

A History of Glaucoma Pharmacology

Journal

OPTOMETRY AND VISION SCIENCE
Volume 88, Issue 1, Pages 36-38

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/OPX.0b013e3182058ead

Keywords

glaucoma; pharmacology; history

Categories

Funding

  1. Research to Prevent Blindness, Inc.
  2. Alcon Laboratories
  3. Aqueous Biomedical
  4. Pfizer, Inc.

Ask authors/readers for more resources

The history of glaucoma pharmacology begins in 1862 with the isolation of physostigmine from the calabar bean. The discovery of epinephrine's intraocular pressure lowering capacity came along some 40 years later. During the 20th century, drug discovery and development accelerated, with the introduction of carbonic anhydrase inhibitors, beta blockers, and prostaglandin analogs. This survey of the history of glaucoma medications reviews some of the pivotal stories behind the development of the drugs that we use daily to manage our patients with glaucoma. In addition, some unmet needs that persist in glaucoma pharmacology are discussed. (Optom Vis Sci 2011; 88: 36-38)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available